| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.27B | 42.84B | 44.56B | 46.43B | 40.76B | 36.50B |
| Gross Profit | 8.04B | 7.72B | 7.81B | 10.43B | 8.98B | 6.21B |
| EBITDA | 3.73B | 3.82B | 3.45B | 5.50B | 4.55B | 2.41B |
| Net Income | 2.11B | 2.13B | 1.69B | 3.06B | 2.57B | 1.28B |
Balance Sheet | ||||||
| Total Assets | 52.89B | 52.06B | 58.19B | 54.04B | 52.52B | 45.57B |
| Cash, Cash Equivalents and Short-Term Investments | 6.93B | 6.70B | 9.60B | 8.33B | 8.14B | 8.41B |
| Total Debt | 7.15B | 5.74B | 5.90B | 6.25B | 6.62B | 6.84B |
| Total Liabilities | 21.80B | 20.48B | 22.18B | 21.82B | 23.68B | 19.36B |
| Stockholders Equity | 30.59B | 31.11B | 35.60B | 31.86B | 28.64B | 26.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.84B | 2.41B | 1.00B | 294.00M | 772.00M |
| Operating Cash Flow | 0.00 | 2.73B | 2.87B | 2.07B | 1.22B | 2.31B |
| Investing Cash Flow | 0.00 | 590.00M | -683.00M | -1.07B | -849.00M | -671.00M |
| Financing Cash Flow | 0.00 | -6.05B | -1.05B | -896.00M | -729.00M | -1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥28.08B | 13.36 | ― | 4.07% | -7.15% | ― | |
69 Neutral | ¥23.67B | 12.41 | ― | 6.09% | -3.75% | 54.88% | |
68 Neutral | ¥15.10B | 15.25 | ― | 1.71% | -4.31% | 8.40% | |
67 Neutral | ¥36.80B | 25.92 | ― | 4.86% | -0.95% | 2.98% | |
64 Neutral | ¥30.53B | 6.02 | ― | 7.09% | -13.08% | -34.23% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
44 Neutral | ¥6.68B | -0.94 | ― | ― | 3.22% | -451.22% |